[HTML][HTML] The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches

A Drobny, SP Huarcaya, J Dobert, A Kluge… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Lysosomes are ubiquitous organelles with a fundamental role in maintaining cellular
homeostasis by mediating degradation and recycling processes. Cathepsins are the most …

Neurodegeneration and neuroinflammation in Parkinson's disease: a self-sustained loop

G Arena, K Sharma, G Agyeah, R Krüger… - Current Neurology and …, 2022 - Springer
Abstract Purpose of Review Neuroinflammation plays a significant role in Parkinson's
disease (PD) etiology along with mitochondrial dysfunction and impaired proteostasis. In this …

Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives

S Incontro, ML Musella, M Sammari… - Physiological …, 2025 - journals.physiology.org
Lipids represent the most abundant molecular type in the brain, with a fat content of∼ 60%
of the dry brain weight in humans. Despite this fact, little attention has been paid to …

Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models

S Prieto Huarcaya, A Drobny, ARA Marques… - Autophagy, 2022 - Taylor & Francis
Parkinson disease (PD) is a neurodegenerative disorder characterized by the abnormal
intracellular accumulation of SNCA/α-synuclein. While the exact mechanisms underlying …

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease

X Zhang, H Wu, B Tang, J Guo - Translational Neurodegeneration, 2024 - Springer
Parkinson's disease (PD) is the second most common neurodegenerative disease. The
development of PD is closely linked to genetic and environmental factors, with GBA1 …

Gaucher disease provides a unique window into Parkinson disease pathogenesis

E Hertz, Y Chen, E Sidransky - Nature Reviews Neurology, 2024 - nature.com
An exciting development in the field of neurodegeneration is the association between the
rare monogenic disorder Gaucher disease and the common complex disorder Parkinson …

Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models

A Drobny, FA Boros, D Balta, S Prieto Huarcaya… - Translational …, 2023 - Springer
Background Lysosomal dysfunction has been implicated in a number of neurodegenerative
diseases such as Parkinson's disease (PD). Various molecular, clinical and genetic studies …

The lysosomal β-glucocerebrosidase strikes mitochondria: Implications for Parkinson's therapeutics

JC Rubilar, TF Outeiro, AD Klein - Brain, 2024 - academic.oup.com
Parkinson's disease (PD) is a neurodegenerative disorder primarily known for typical motor
features that arise due to the loss of dopaminergic neurons in the substantia nigra. However …

High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson's disease

D Williams, LM Glasstetter, TT Jong, T Chen… - Proceedings of the …, 2024 - pnas.org
Glucocerebrosidase (GCase) is implicated in both a rare, monogenic disorder (Gaucher
disease, GD) and a common, multifactorial condition (Parkinson's disease, PD); hence, it is …

A Biomarker Study in Patients with GBA1‐Parkinson's Disease and Healthy Controls

JM den Heijer, VC Cullen, DR Pereira… - Movement …, 2023 - Wiley Online Library
Background Molecules related to glucocerebrosidase (GCase) are potential biomarkers for
development of compounds targeting GBA1‐associated Parkinson's disease (GBA‐PD) …